ImmunologybioRxivPreprint
Stealth CAR-Tregs evade CD3 antibody therapy and skew immune responses toward regulation
Tifanie Blein, Nicolas Ayas, Soëli Charbonnier…·Julien Zuber
This study shows that TRAC-/-CAR-Tregs survive CD3 antibody therapy better than TRAC+/+CAR-Tregs, shifting immune responses toward regulation.